Secondary Outcomes (end points)
We will also study the following outcomes:
1) Share of respondents who report that the amount of public attention and spending on policies to decrease overdose deaths is “too much” or “just right.”
2) Share of respondents who select that “opioid use is a choice and people should just not use opioids.” (This answer is only an option for respondents who previously answered that the amount of public attending and spending dedicated to decrease overdose deaths is “too much” or “just right.” Those not given this question will be assigned to not answering that “opioid use is a choice and people should just not use opioids.”)
3) Maximum willingness-to-pay for naloxone policy that would reduce overdose deaths by 1 / 100,000.
4) Share who agree or strongly agree that opioid addiction is a choice. (We will also study each option separately: strongly agree, agree, neither agree or disagree, disagree, strongly disagree)
5) Share who answer that those found misusing opioids should serve jail time.
6) Share who believe that prisons should provide MOUD to prisoners.
7) Share who believe that prisons should provide naloxone to prisoners upon release.
Our sample includes a “nationally-representative sample” and an “opioid-dependent sample.” We will conduct analyses of our primary and secondary outcomes for each sample separately as secondary analyses. When making this stratification, we will rely on our own questions about opioid dependence.
In addition, we will make the same comparisons for stratified samples: (1) people who know someone impacted by opioids in any of the following ways: (a) struggled with an opioid addiction, (b) needed medical attention because of an opioid addiction, (c) sought treatment for an opioid addiction, (d) Faced police contact, arrest, or incarceration due to an opioid addiction, or (e) are likely or very likely to overdose from opioid use; (2) people who are personally impacted by opioid use (same reasons as above) or report being likely or very likely to overdose from opioid use. In each stratification, we will show the comparable results for the sample not meeting the conditions.
(3) We will also stratify by race, gender, and political affiliation.
(4) Finally, we will stratify based on the 2022 overdose death rate of the state.